On the Call: Johnson & Johnson CEO Alex Gorsky

Johnson & Johnson CEO Gorsky sees higher sales growth rate continuing in emerging markets

Associated Press

During a conference call to review Johnson & Johnson's fourth-quarter results, analysts and company executives discussed sales in emerging markets — countries where governments and a growing middle class are now spending more on health care. Those are led by the so-called BRIC countries: Brazil, Russia, India and China. Makers of drugs and other health products increasingly have been targeting such countries for growth, because it's slowed or stalled in wealthier nations. J&J said emerging markets accounted for 22 percent of its total 2013 revenue of $71.3 billion.

Question: What trends are you seeing in sales across emerging markets?

Answer: We think there's a big growth opportunity in emerging markets. Despite some ups and downs, we will likely continue to grow at three to four times the rate we're seeing in developed countries.

View Comments